Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

2.

Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.

Weiss G, Schlegel A, Kottwitz D, König T, Tetzner R.

J Thorac Oncol. 2017 Jan;12(1):77-84. doi: 10.1016/j.jtho.2016.08.123. Epub 2016 Aug 18.

3.

Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.

Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, Koenig T, Quigley NB, Weiss G.

Clin Chem. 2014 Sep;60(9):1183-91. doi: 10.1373/clinchem.2013.221044. Epub 2014 Jun 17.

4.

Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging.

Darwiche K, Zarogoulidis P, Baehner K, Welter S, Tetzner R, Wohlschlaeger J, Theegarten D, Nakajima T, Freitag L.

Ann Oncol. 2013 Nov;24(11):2866-70. doi: 10.1093/annonc/mdt365. Epub 2013 Sep 11.

PMID:
24026539
5.

TFAP2E-DKK4 and chemoresistance in colorectal cancer.

Ebert MP, Tänzer M, Balluff B, Burgermeister E, Kretzschmar AK, Hughes DJ, Tetzner R, Lofton-Day C, Rosenberg R, Reinacher-Schick AC, Schulmann K, Tannapfel A, Hofheinz R, Röcken C, Keller G, Langer R, Specht K, Porschen R, Stöhlmacher-Williams J, Schuster T, Ströbel P, Schmid RM.

N Engl J Med. 2012 Jan 5;366(1):44-53. doi: 10.1056/NEJMoa1009473.

6.

SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.

Schmidt B, Liebenberg V, Dietrich D, Schlegel T, Kneip C, Seegebarth A, Flemming N, Seemann S, Distler J, Lewin J, Tetzner R, Weickmann S, Wille U, Liloglou T, Raji O, Walshaw M, Fleischhacker M, Witt C, Field JK.

BMC Cancer. 2010 Nov 3;10:600. doi: 10.1186/1471-2407-10-600.

7.

A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation.

Tierling S, Schuster M, Tetzner R, Walter J.

Epigenetics Chromatin. 2010 Jun 2;3(1):12. doi: 10.1186/1756-8935-3-12.

8.

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.

deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton-Day C.

Clin Chem. 2009 Jul;55(7):1337-46. doi: 10.1373/clinchem.2008.115808. Epub 2009 Apr 30.

9.

Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues.

Dietrich D, Lesche R, Tetzner R, Krispin M, Dietrich J, Haedicke W, Schuster M, Kristiansen G.

J Histochem Cytochem. 2009 May;57(5):477-89. doi: 10.1369/jhc.2009.953026. Epub 2009 Jan 19.

10.

Prevention of PCR cross-contamination by UNG treatment of bisulfite-treated DNA.

Tetzner R.

Methods Mol Biol. 2009;507:357-70. doi: 10.1007/978-1-59745-522-0_26.

PMID:
18987827
11.

DNA methylation biomarkers for blood-based colorectal cancer screening.

Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, Molnar B, Grützmann R, Pilarsky C, Sledziewski A.

Clin Chem. 2008 Feb;54(2):414-23. Epub 2007 Dec 18.

12.

Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA.

Tetzner R, Dietrich D, Distler J.

Nucleic Acids Res. 2007;35(1):e4. Epub 2006 Nov 28.

13.

A real-time PCR assay for DNA-methylation using methylation-specific blockers.

Cottrell SE, Distler J, Goodman NS, Mooney SH, Kluth A, Olek A, Schwope I, Tetzner R, Ziebarth H, Berlin K.

Nucleic Acids Res. 2004 Jan 13;32(1):e10.

Supplemental Content

Loading ...
Support Center